GC
CPRX

Globeflex Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Globeflex Capital’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2M Buy
450,580
+158,372
+54% +$3.77M 1.69% 5
2025
Q4 		$6.82M Buy
292,208
+1,529
+0.5% +$34.1K 1.04% 22
2025
Q3 		$5.73M Sell
290,679
-7,408
-2% -$152K 0.88% 29
2025
Q2 		$6.47M Buy
298,087
+43,901
+17% +$1.04M 0.54% 43
2025
Q1 		$6.16M Buy
254,186
+59,400
+30% +$1.34M 0.57% 40
2024
Q4 		$4.07M Buy
194,786
+148,388
+320% +$3.19M 0.34% 72
2024
Q3 		$922K Sell
46,398
-182,386
-80% -$3.38M 0.09% 193
2024
Q2 		$3.54M Hold
228,784
– – 0.37% 65
2024
Q1 		$3.65M Hold
228,784
– – 0.36% 63
2023
Q4 		$3.85M Sell
228,784
-5,500
-2% -$75.2K 0.39% 64
2023
Q3 		$2.74M Sell
234,284
-62,212
-21% -$832K 0.32% 82
2023
Q2 		$3.98M Sell
296,496
-7,695
-3% -$111K 0.44% 66
2023
Q1 		$5.04M Sell
304,191
-44
-0% -$726 0.62% 37
2022
Q4 		$5.66M Sell
304,235
-58
-0% -$893 0.72% 32
2022
Q3 		$3.9M Sell
304,293
-222
-0.1% -$2.63K 0.67% 27
2022
Q2 		$2.13M Hold
304,515
– – 0.52% 39
2022
Q1 		$2.52M Hold
304,515
– – 0.51% 38
2021
Q4 		$2.06M Hold
304,515
– – 0.42% 55
2021
Q3 		$1.61M Sell
304,515
-306,592
-50% -$1.68M 0.35% 72
2021
Q2 		$3.51M Buy
611,107
+616
+0.1% +$3.18K 0.63% 23
2021
Q1 		$2.81M Buy
610,491
+234,284
+62% +$931K 0.51% 45
2020
Q4 		$1.26M Buy
+376,207
New +$1.26M 0.27% 121

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Globeflex Capital's CPRX Position: Q1 2026 in Review

Globeflex Capital increased its Catalyst Pharmaceutical (CPRX) stake by 54% in Q1 2026, buying an estimated $3.77M and bringing the position to 450,580 shares worth $11.2M. The position accounts for 1.69% of the portfolio, ranked #5.

Globeflex Capital first reported a position in CPRX in Q4 2020 and has held it in 22 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Globeflex Capital held 450,580 shares of Catalyst Pharmaceutical worth $11.2M as of Q1 2026.
  • Globeflex Capital bought 158,372 Catalyst Pharmaceutical shares in Q1 2026, an estimated $3.77M.
  • Catalyst Pharmaceutical made up 1.69% of Globeflex Capital's portfolio in Q1 2026, its #5 holding.
  • Globeflex Capital first reported a position in Catalyst Pharmaceutical in Q4 2020 and has held it in 22 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.